Discovery of N-(Naphtho[1,2-b]Furan-5-Yl) Benzenesulfonamides as Novel Selective Inhibitors of Triple-Negative Breast Cancer (TNBC)

Any type of breast cancer not expressing genes of the estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER2) is referred to as triple-negative breast cancer (TNBC). Accordingly, TNBCs do not respond to hormonal therapies or medicines targeting the ER,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ya, Tang, Yong, Mao, Beibei, Li, Wenchao, Jin, Hongwei, Zhang, Liangren, Liu, Zhenming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017705/
https://www.ncbi.nlm.nih.gov/pubmed/29547591
http://dx.doi.org/10.3390/molecules23030678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017705/
https://www.ncbi.nlm.nih.gov/pubmed/29547591
http://dx.doi.org/10.3390/molecules23030678

Ejemplares similares